CLAIAug 21, 2025

RadReason: Radiology Report Evaluation Metric with Reasons and Sub-Scores

arXiv:2508.15464v11 citationsh-index: 7
Originality Incremental advance
AI Analysis

This addresses the need for clinically grounded and interpretable metrics in radiology report evaluation, though it is incremental as it builds on existing optimization methods.

The paper tackled the challenge of evaluating automatically generated radiology reports by introducing RadReason, a framework that provides fine-grained sub-scores and human-readable justifications, achieving parity with GPT-4-based evaluations on the ReXVal benchmark.

Evaluating automatically generated radiology reports remains a fundamental challenge due to the lack of clinically grounded, interpretable, and fine-grained metrics. Existing methods either produce coarse overall scores or rely on opaque black-box models, limiting their usefulness in real-world clinical workflows. We introduce RadReason, a novel evaluation framework for radiology reports that not only outputs fine-grained sub-scores across six clinically defined error types, but also produces human-readable justifications that explain the rationale behind each score. Our method builds on Group Relative Policy Optimization and incorporates two key innovations: (1) Sub-score Dynamic Weighting, which adaptively prioritizes clinically challenging error types based on live F1 statistics; and (2) Majority-Guided Advantage Scaling, which adjusts policy gradient updates based on prompt difficulty derived from sub-score agreement. Together, these components enable more stable optimization and better alignment with expert clinical judgment. Experiments on the ReXVal benchmark show that RadReason surpasses all prior offline metrics and achieves parity with GPT-4-based evaluations, while remaining explainable, cost-efficient, and suitable for clinical deployment. Code will be released upon publication.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes